Results 1 to 10 of about 684,930 (357)

Radiotherapy as a primary treatment modality for a young man with a primary urethral plasmacytoma: case report and literature review [PDF]

open access: yesFrontiers in Oncology
Primary urethral plasmacytoma is an extremely rare form of solitary plasmacytoma, with only 10 cases reported in the literature. It involves localized clonal proliferation of plasma cells without systemic disease.
Soo How Lim   +9 more
doaj   +2 more sources

Optimising the MR‐Linac as a standard treatment modality [PDF]

open access: yesJournal of Medical Radiation Sciences, 2023
The magnetic resonance linear accelerator (MR‐Linac) offers a new treatment paradigm, providing improved visualisation of targets and organs at risk while allowing for daily adaptation of treatment plans in real time.
Jeremy deLeon   +4 more
doaj   +2 more sources

Focused ultrasound as a treatment modality for gliomas [PDF]

open access: yesFrontiers in Neurology
Ultrasound waves were initially used as a diagnostic tool that provided critical insights into several pathological conditions (e.g., gallstones, ascites, pneumothorax, etc.) at the bedside.
Divine C. Nwafor   +4 more
doaj   +2 more sources

Chemoradiation for oesophageal cancer: the choice of treatment modality [PDF]

open access: yesRadiation Oncology, 2023
Background Locally advanced oesophageal cancer can be treated with definitive chemoradiation (dCRT) or with neoadjuvant chemoradiation followed by surgery (nCRT + S), but treatment modality choice is not always clear.
Pauliina M. Kitti   +6 more
doaj   +2 more sources

Glivec: A New Treatment Modality for CML: A Case History

open access: diamondCHIMIA, 2002
Glivec (the brand name in the US is Gleevec™) is a protein-tyrosine kinase inhibitor which potently inhibits the AbI tyrosine kinase in vitro and in vivo. The compound specifically inhibits proliferation of v-abl and bcr-abl expressing cells, suggesting
Jürg Zimmermann
doaj   +2 more sources

Attributes underlying patient choice of treatment modality for low-grade squamous intraepithelial lesion complicated by high-risk human papillomavirus infection

open access: yesInternational Journal of Hyperthermia, 2023
Objective To use logistic regression to analyze the attributes underlying patients’ treatment options for low-grade squamous intraepithelial lesion (LSIL) complicated with high-risk human papillomavirus (HR-HPV) infection, and identify the best benefit ...
Miaomiao He   +6 more
doaj   +1 more source

Selection of optimal therapeutic modality for early-stage extranodal natural killer/T-cell lymphoma patients under the guidance of single-nucleotide polymorphism signature

open access: yesBiomolecules & Biomedicine, 2022
The therapeutic modalities of early-stage and advanced extranodal natural killer/T-cell lymphoma (NKTCL) patients are completely different. The former is mainly radiotherapy with or without chemotherapy, while the latter relies on chemotherapy-based ...
Zhe-Sheng Chen, Dong-Hua Yang
doaj   +1 more source

Long-Term Survival Outcomes and Comparison of Different Treatment Modalities for Stage I-III Cervical Esophageal Carcinoma

open access: yesFrontiers in Medicine, 2021
Purpose: To investigate the survival outcomes, prognostic factors and treatment modalities of stage I-III cervical esophageal carcinoma (CEC) patients using data from the Surveillance, Epidemiology, and End Results (SEER) database from the period 2004 ...
Yanwei Lu   +6 more
doaj   +1 more source

Analysis of clinicopathological characteristics and survival of 1 915 oral cavity squamous cell carcinoma patients: 24-year experience from a single institution

open access: yes口腔疾病防治, 2020
Objective To investigate the clinicopathological features and survival rate of oral squamous cell carcinoma patients in China. Methods The clinicopathological characteristics, stage, treatment modality, and 5-year disease-specific survival (DSS) rate of ...
CHEN Shuwei   +10 more
doaj   +1 more source

A current perspective on stereotactic body radiation therapy for pancreatic cancer. [PDF]

open access: yes, 2016
Pancreatic cancer is a formidable malignancy with poor outcomes. The majority of patients are unable to undergo resection, which remains the only potentially curative treatment option.
Czito, Brian G   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy